Spiramycin renaissance

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 5, 1998, Pages 572-576

  Rubinstein, E ^a   Keller, N ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; PENICILLIN V; SPIRAMYCIN;

ADOLESCENT; ADULT; CHILD; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG LIVER LEVEL; DRUG SAFETY; DRUG TISSUE LEVEL; GASTROINTESTINAL SYMPTOM; HUMAN; ORAL DRUG ADMINISTRATION; PNEUMONIA; RESPIRATORY TRACT INFECTION; SHORT SURVEY; SIDE EFFECT; SINUSITIS; TONSILLITIS;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS; DOUBLE-BLIND METHOD; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY TRACT INFECTIONS; SPIRAMYCIN; TISSUE DISTRIBUTION;

EID: 0031768494     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.5.572     Document Type: Short Survey

References (24)

1. Carbon, C. (1993). Clinical efficacy and place of spiramycin in the treatment of acute respiratory tract infections. Drug Investigation 6, Suppl. 1, 35-42.
2. Bergogne-Bérézin, E. (1988). Spiramycin concentrations in the human respiratory tract: a review. Journal of Antimicrobial Chemotherapy 22, Suppl. B, 117-22.
3. Pilot, M. A. & Qin, X. Y. (1988). Macrolides and gastrointestinal motility. Journal of Antimicrobial Chemotherapy 22, Suppl. B, 201-6.
4. Wise, R. (1993). Clinical pharmacokinetics of spiramycin. Drugs Investigation 6, Suppl. 1, 29-34.
5. Baldwin, D. R., Honeybourne, D. & Wise, R. (1992). Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance. Antimicrobial Agents and Chemotherapy 36, 1176-80.
6. Davey, P., Pechère, J.-C. & Speller, D. (Eds) (1988). Spiramycin reassessed. Journal of Antimicrobial Chemotherapy 22, Suppl. B.
7. Bergogne-Bérézin, E. & Hamilton-Miller, J. M. T. (1993). Overview of spiramycin in respiratory tract infections. Drugs Investigation 6, Suppl. 1, 52-4.
8. Kitzis, M., Desnottes, J. F., Brunel, D., Giudicelli, A., Jacotot, F. & Andreassian, B. (1988). Spiramycin concentration in lung tissue. Journal of Antimicrobial Chemotherapy 22, Suppl. B, 123-6.
9. Bergogne-Bérézin, E. (1995). New concepts in the pulmonary disposition of antibiotics. Pulmonary Pharmacology 8, 65-81.
10. Marrie, T. J., Peeling, R. W., Fine, M. J., Singer, D. E., Coley, C. M. & Kapoor, W. N. (1996). Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. American Journal of Medicine 101, 508-15.
11. Desnottes, J. F., Diallo, N. & Moret, G. (1998). Effects of spiramycin on adhesiveness and phagocytosis of Gram-positive cocci. Journal of Antimicrobial Chemotherapy 22, Suppl. B, 25-32.
12. Frydman, A. M., Le Roux, Y., Desnottes, J. F., Kaplan, P., Djebbar, F., Cournot, A. et al. (1988). Pharmacokinetics of spiramycin in man. Journal of Antimicrobial Chemotherapy 22, Suppl. B, 93-103.
13. Kavi, J., Webberley, J. M., Andrews, J. M. & Wise, R. A (1988). A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycin. Journal of Antimicrobial Chemotherapy 22, Suppl. B, 105-10.
14. Levrat, M., Brette, R. & Truchot, R. (1964). L'élimination biliaire des antibiotiques. Revue Internationale d'Hepatologie 14, 137-69.
15. Boezeman, A. J., Kayser, A. M. & Siemelink, R. J. (1988). Comparison of spiramycin and doxycycline in the empirical treatment of acute sinusitis: preliminary results. Journal of Antimicrobial Chemotherapy 22, Suppl. B, 165-70.
16. Gendrel, D., Bourrillon, A., Bingen, E., Raymond, J., Lilienthal, F. & Touron, D. (1997). Five-day spiramycin versus seven-day penicillin V in the treatment of streptococcal tonsillitis in children. Clinical Drug Investigation 13, 338-44.
17. Manolopoulos, L., Adamopoulos, C., Tzagourolakis, A., Maragoudakis, P. & Kaffes, T. (1989). Spiramycin versus penicillin V in the empiric treatment of bacterial tonsillitis. British Journal of Clinical Practice 43, 94-6.
18. Biermann, C., Loken, A. & Ruse, R. (1988). Comparison of spiramycin and doxycycline in the treatment of lower respiratory infections in general practice. Journal of Antimicrobial Chemotherapy 22, Suppl. B, 155-8.
19. Jeannin, L., Vergeret, J., Caillaud, D., Poirier, R., Vandevenne, A. & Verken, J. B. (1992). Community-acquired pneumonia in healthy adults: 188 patients treated with spiramycin in private practice. Revue de Pneumologie Clinique 48, 263-8.
20. De Cock, L. & Poels, R. (1988). Comparison of spiramycin and erythromycin for lower respiratory tract infections. Journal of Antimicrobial Chemotherapy 22, Suppl. B, 159-63.
21. Kernbaum, S. (1982). Spiramycin - therapeutic value in humans. Semaine des Hopitaux de Paris 58, 289-97.
22. Denie, C., Henrion, J., Schapira, M., Schmitz, A. & Heller, F. R. (1992). Spiramycin-induced cholestatic hepatitis. Journal of Hepatology 16, 386.
23. Descotes, J. (1993). Chemical structure and safety of spiramycin. Drug Investigation 6, Suppl. 1, 43-8.
24. Pessayre, D., Larrey, D., Funck-Brentano, C. & Benhamou, J. P. (1985). Drug interactions and hepatitis produced by some macrolide antibiotics. Journal of Antimicrobial Chemotherapy 16, Suppl. A, 181-94.